Hong Kong stocks surge again, with the Federal Pharmaceutical (03933.HK) rising more than 4%. Overseas authorization of UBT251 boosts performance, with first half net profit increasing by over 24% year-on-year.

According to the Wisdom Financial APP, Federal Pharmaceutical (03933.HK) has risen by over 4% again, as of the time of publication, it has increased by 3.59%, reaching 17.61 Hong Kong dollars, with a turnover of 1.47 billion Hong Kong dollars.